StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 71.3%, against 100.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202571.3%−28.7
FY2024Dec 31, 2024100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-70.6%–
Q1 FY2026Mar 31, 2026-58.9%–
Q1 FY2025Mar 31, 2025100.0%–

More Dare Bioscience figures

See a number that looks wrong?